Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2014
04/30/2014CN103764165A Drug for preventing exacerbation of malignant tumor, comprising combination of natriuretic peptide receptor GC-A agonist and GC-B agonist
04/30/2014CN103764163A Plasminogen and plasmin variants
04/30/2014CN103764162A Peptide linkers for polypeptide compositions and methods for using same
04/30/2014CN103764161A Anti-cancer composition comprising Wnt decoy receptors
04/30/2014CN103764160A Assays for influenza virus hemagglutinins
04/30/2014CN103764159A Aromatic-cationic peptides and uses of same
04/30/2014CN103764156A Formulations containing saccharomyces boulardii and superoxide dismutase (sod) to control obesity
04/30/2014CN103764137A Eosinophil peroxidase compositions and methods of their use
04/30/2014CN103757041A Method for preparing swine-original interferon-gamma 3 and application
04/30/2014CN103757026A Gene sequence and polypeptide of FGFR2b ectodomain and application thereof
04/30/2014CN103755814A TAT-IL-24-KDEL fusion protein as well as preparation method and application thereof
04/30/2014CN103755813A Targeting anti-tumor fusion protein, and encoding gene and expression plasmid thereof
04/30/2014CN103755810A Long-acting HIV-1 membrane fusion inhibitor
04/30/2014CN103755801A Application of combination of earthworm fibrinolytic-activity protein and paclitaxel in preparing drugs for inhibiting cancer cells
04/30/2014CN103755800A Modified human growth hormone polypeptides and their uses
04/30/2014CN103755799A Tumstatin No.30 peptide having anti-tumor effect, and preparation method and application thereof
04/30/2014CN103755798A Bufo gargarizans antimicrobial peptide BG-SK14, and coding gene and application thereof
04/30/2014CN103755797A Antimicrobial peptide BG-CATH6 (5-29) of Bufo bufo gargarizans as well as encoding genes and application of antimicrobial peptide BG-CATH6 (5-29) of Bufo bufo gargarizans
04/30/2014CN103755796A Amolops Hainan ensis anticancer peptides Hainanenin-1 as well as gene and application thereof
04/30/2014CN103755795A Saddletail grouper antimicrobial peptide LEAP-2 gene, vector, recombinant strain and protein, and application thereof
04/30/2014CN103755789A Regulatory T cell epitopes, compositions and uses thereof
04/30/2014CN103755788A Polypeptide for inhibiting immune globulin K light-chain gene enhancer protein and application thereof
04/30/2014CN103755786A Melanocortin receptor ligands
04/30/2014CN103755784A Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide
04/30/2014CN103755783A Dipeptide QD with double functions of lowering blood pressure and lowering blood fat and application thereof
04/30/2014CN103755782A Dipeptide ST with double functions of lowering blood pressure and lowering blood fat and application thereof
04/30/2014CN103755781A Dipeptide GD with double functions of reducing blood pressure and blood fat and purposes thereof
04/30/2014CN103751804A Application of interferon regulatory factor 4 (IRF4) gene in coronary atherosclerotic heart disease
04/30/2014CN103751796A Straight-chain polyethylene glycol-recombinant porcine interferon alpha conjugate, and preparing method and application thereof
04/30/2014CN103751770A Medical ray protection washing agent
04/30/2014CN103751769A Lyophilized recombinant human growth hormone capsule and preparation method thereof
04/30/2014CN103751768A Preparation helping to heal wound
04/30/2014CN103751767A Medicament composition and application thereof
04/30/2014CN103751766A Use of cobra venom cardiotoxins in preparation of drug for diminishing inflammation, easing pain and resisting arthritis
04/30/2014CN103751765A Application of recombined ganoderma lucidum immunoregulation protein (rLZ-8) to preparation of medicine for treating tissue fibrosis
04/30/2014CN103751764A Application of BAT3 (HLA-B-associated transcript 3) protein in preparing medicine for treating nervous system diseases caused by prion
04/30/2014CN103751763A Methods for the prevention or treatment of vessel occlusion injury
04/30/2014CN103751762A Product for promoting skin cell reconstruction and delaying senescence
04/30/2014CN103751211A Methods and pharmaceutical compositions for healing wounds
04/30/2014CN103751150A Method for preparing insulin sustained-release capsules from attapulgite
04/30/2014CN103751102A Collagenase thermoresponsive hydrogel and preparation method and application of hydrogel
04/30/2014CN103751098A Recombinant human interferon alpha 2a vaginal expansion suppository and preparation and detection methods thereof
04/30/2014CN103750344A Yeast glutathione nutrition preparation
04/30/2014CN103750024A Feed for treating urinary retention of sow and preparation method of feed
04/30/2014CN103169945B Application of cyclopeptide in preparation of medicine for treating or preventing atherosclerosis
04/30/2014CN102952185B Novel defensin pdBD, and gene and application thereof
04/30/2014CN102898508B Polypeptide for enclosing TGF-beta acceptor or IL-10 acceptor, pharmaceutical composition and application
04/30/2014CN102755669B Preparation method and application of fibrin glue composite recombinant human bone morphogenetic protein-2 (rhBMP-2) microsphere
04/30/2014CN102727870B Use of salcatonin
04/30/2014CN102718870B Insulin bio-sensitizer and application thereof
04/30/2014CN102665751B Anti-androgenic agent, sebum secretion blocker, hair growth stimulant, and food or beverage
04/30/2014CN102596219B Novel bacteriophage and antibacterial composition comprising the same
04/30/2014CN102580057B Medicine composition containing ergometrine and oxytocin analogue and preparation method
04/30/2014CN102372770B Angiogenesis inhibitant, purification method and medicinal composition therewith
04/30/2014CN102307587B Use of APL-type peptide for treating intestinal inflammatory diseases and type 1 diabetes
04/30/2014CN102302770B Medical composition for accelerating wound healing
04/30/2014CN102215837B Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor
04/30/2014CN101925364B 14-3-3 antagonists for prevention and treatment of arthritis
04/30/2014CN101890181B Swine fibrin glue powder inhalation and preparation method and application thereof
04/30/2014CN101848926B Peptide capable of binding to immunoglobulin
04/30/2014CN101843897B Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
04/30/2014CN101724075B Remodeling and glycoconjugation of peptides
04/30/2014CN101573373B Cyclic angiotensin analogs
04/30/2014CN101500605B Use of Dll4 antagonists in treating local ischemic injury
04/30/2014CN101484002B Detection of protease and protease activity using a single nanocrescent sers probe
04/30/2014CA2794719A1 A method for treating or preventing either one or both of an inflammatory disease and an autoimmune disease
04/29/2014US8710229 Hepatitis C virus inhibitors
04/29/2014US8710205 Transcription factor
04/29/2014US8710188 Factor IXa crystals, related complexes and methods
04/29/2014US8710187 Modified binding proteins inhibiting the VEGF-A receptor interaction
04/29/2014US8710184 Motilin-like peptide compound having transmucosal absorbability imparted thereto
04/29/2014US8710183 Inhibitors of bacterial tyrosine kinase and uses thereof
04/29/2014US8710181 Use of tris(hydroxymethyl) aminomethane for the stabilization of peptides, polypeptides and proteins
04/29/2014US8710180 VEGF-specific capture agents, compositions, and methods of using and making
04/29/2014US8710179 Compositions and methods for concentrating and depleting microorganisms
04/29/2014US8710178 Macrocyclic cysteine protease inhibitors and compositions thereof
04/29/2014US8710025 Modified and stabilized GDF propeptides and uses thereof
04/29/2014US8710023 Antisense modulation of C-reactive protein expression
04/29/2014US8710017 Human and mouse targeting peptides identified by phage display
04/29/2014US8710016 ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
04/29/2014US8710015 Tropoelastin derivatives
04/29/2014US8710014 Compositions and methods for inhibition of MMP13:MMP-substrate interactions
04/29/2014US8710013 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
04/29/2014US8710012 Method for treating oncological diseases
04/29/2014US8710011 Cosmetic or pharmaceutical peptides containing uncoded amino acids and their use in the treatment and/or care of the skin, mucous membranes, or scalp
04/29/2014US8710010 Peptides useful in the treatment and/or care of skin, mucous membranes, scalp and/or hair and their use in cosmetic or pharmaceutical compositions
04/29/2014US8710009 HSP20 inhibits amyloidogenesis and neurotoxicity
04/29/2014US8710008 Compounds, compositions and use
04/29/2014US8710007 Prevention and reduction of blood loss
04/29/2014US8710005 Neuronal differentiation-inducing peptide and use thereof
04/29/2014US8710004 Stable liquid VEGF antagonist formulations
04/29/2014US8710003 Treatment of diabetes with milk protein hydrolysate
04/29/2014US8710002 Methods of enhancing diabetes resolution
04/29/2014US8710001 PEGylated, extended insulins
04/29/2014US8710000 Insulin derivative
04/29/2014US8709999 Substituted bicyclic HCV inhibitors
04/29/2014US8709998 Peptide vectors
04/29/2014US8709997 Prevention and treatment of osteoarthritis
04/29/2014US8709996 Pharmaceutical treatment process using chitosan or derivative thereof
04/29/2014US8709995 Method for eliciting an immune response to human telomerase reverse transcriptase
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 3163